Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Vos
Institution:
The Netherlands Cancer Institute
Observed institution:
The Netherlands Cancer Institute
OpenAlex ID:
A5159559974
Predictors of ibandronate treatment benefit in patients of the randomized phase III TEAM-IIB clinical trial; A 10-year follow-up analysis
2026
·
J. Vos
, E. Meershoek-Klein Kranenbarg
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
